Suppr超能文献

不同程度肝性脑病(HE)患者的工作记忆:一项 EEG-fNIRS 的初步研究。

Working Memory in Patients with Varying Degree of Hepatic Encephalopathy (HE): A Pilot EEG-fNIRS Study.

机构信息

Department of Medicine, University of Padova, Via Giustiniani 2, Padova, 35128, Italy.

Chronobiology Section, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

出版信息

Neurochem Res. 2024 Jun;49(6):1529-1540. doi: 10.1007/s11064-023-04034-3. Epub 2023 Oct 4.

Abstract

It is known that patients with covert hepatic encephalopathy (CHE) exhibit working memory abnormalities, but to date there is no study comparing patients with cirrhosis with/without CHE and controls with both electrophysiological and hemodynamic data collected at the same time.Here we collected behavioral [accuracy and reaction times (RTs), electrophysiological (evoked potentials) and hemodynamic (oxygenated and deoxygenated haemoglobin) correlates of an n-back task [formed by a control (0-back) condition, a low (1-back) and a high (2-back) working memory load conditions] in patients with cirrhosis with/without CHE: (1) at baseline (n = 21, males = 15, 58±8 yrs), and by comparison with controls (n = 21, males = 15, 57±11 yrs) and (2) after a 3-month course of rifaximin (n = 18, males = 12, 61±11 yrs), and by comparison to baseline.All patients showed slower RTs (p < 0.0001) and lower P2 amplitude compared with controls (p = 0.018); moreover, patients with CHE showed reduced accuracy (p < 0.0001) compared with controls, and patients without CHE showed higher oxygenated haemoglobin in the central dorsolateral prefrontal cortex in the 2-back compared with patients with CHE. Post-rifaximin, oxygenated haemoglobin increased in the central frontopolar cortex. In addition, in patients without CHE the RTs of the 2-back became comparable to those of the 0-back and P3 showed higher amplitude.In conclusion, the presence of cirrhosis seemed to have more effects than CHE on working memory at baseline. A course of treatment with rifaximin was more beneficial to patients without CHE, who probably had more room for improvement in this complex task.

摘要

已知隐匿性肝性脑病(CHE)患者表现出工作记忆异常,但迄今为止,尚无研究比较同时采集电生理和血流动力学数据的肝硬化伴/不伴 CHE 患者和对照组。在这里,我们收集了行为[准确性和反应时间(RT)、电生理(诱发电位)和血流动力学(含氧和去氧血红蛋白)与 n-back 任务[由控制(0-back)条件、低(1-back)和高(2-back)工作记忆负荷条件]相关的指标,在肝硬化伴/不伴 CHE 的患者中:(1)在基线时(n=21,男性=15,58±8 岁),并与对照组(n=21,男性=15,57±11 岁)进行比较,(2)在接受利福昔明治疗 3 个月后(n=18,男性=12,61±11 岁),并与基线相比。所有患者的 RT 均较慢(p<0.0001),与对照组相比 P2 振幅较低(p=0.018);此外,CHE 患者的准确性较低(p<0.0001),与 CHE 患者相比,无 CHE 患者在 2-back 时中央背外侧前额叶皮质的含氧血红蛋白升高。利福昔明治疗后,中央额极皮质的含氧血红蛋白增加。此外,在无 CHE 的患者中,2-back 的 RT 变得与 0-back 相当,P3 的振幅更高。总之,在基线时,肝硬化的存在似乎比对 CHE 的影响更大。利福昔明治疗对无 CHE 的患者更有益,这些患者在这项复杂任务中可能有更大的改善空间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验